CYP 332 (Nexphen PD 200 mg-7.5 mg)
Generic Name: guaifenesin/phenylephrine
Pill imprint CYP 332 has been identified as Nexphen PD 200 mg-7.5 mg.
Nexphen PD is used in the treatment of sinus symptoms; cough and nasal congestion and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Nexphen PD 200 mg-7.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- CYP 332
- 200 mg-7.5 mg
- Rx and/or OTC
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Cypress Pharmaceutical Inc
- National Drug Code (NDC):
More about Nexphen PD (guaifenesin / phenylephrine)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- 0 Reviews – Add your own review/rating
- Drug class: upper respiratory combinations
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.